News
Anti-inflammatory drugs ineffective for prevention of Alzheimerās disease
![](/psychiatry/files/psychiatry/styles/fullwidth_breakpoints_theme_moriarty_small_1x/public/channels/image/adobestock_205861998.jpeg?itok=ZAASXEsS×tamp=1555335205)
Published: 15 April 2019
Study sheds light on longstanding debate
Researchers have known for decades that inflammation accompanies Alzheimerās disease (AD) brain lesions. Several early studies suggested that āsuper-aspirinsā or Nonsteroidal anti-inflammatory drugs (NSAID) could help avoid the disease. However, after clinical trials showed that NSAIDs donāt help patients who already have AD symptoms, doctors wondered whether these drugs could still be helpful to people who were at risk of developing the disease, but werenāt yet showing symptoms.
Read the story and access the study .